Patient-Centered Study on Treatment Choices for Degenerative Mitral Valve Prolapse Comparing Surgical Repair and Transcatheter Edge-to-Edge Repair

What this Trial Is About

Researchers are conducting a study to understand the decision-making process for patients with degenerative mitral valve prolapse who must choose between surgical mitral valve repair MVR and transcatheter edge-to-edge repair TEER. This study focuses on gathering information from both patients and healthcare providers about the outcomes that matter most to them. The goal is to develop tools that support shared decision making within heart valve care teams, helping patients and providers make informed choices together. The study involves qualitative focus groups and quantitative surveys. Patients with severe mitral regurgitation and healthcare providers such as cardiac surgeons and cardiologists will participate in focus groups to discuss important treatment outcomes. Following this, surveys will assess how patients and providers prioritize these outcomes. Additionally, focus groups with multidisciplinary heart valve teams will explore challenges and supports for shared decision making in clinical care. Participants will engage in discussions and complete surveys that explore their preferences and priorities regarding treatment outcomes. Researchers will analyze these data to identify key factors influencing decision making and to map workflows for integrating shared decision making in practice. The study aims to identify important outcome measures and barriers to shared decision making over a one-year period, providing insights to improve patient-centered care for mitral valve prolapse.

Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse